Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-01-13 @ 5:15 PM
Study NCT ID:
NCT03428802
Status:
RECRUITING
Last Update Posted:
2022-11-18
First Post:
2018-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
Sponsor:
Organization: